Source: Pharmacy Times articles
Ranibizumab injection (Susvimo; Genentech) could offer long-lasting vision preservation and reduce the need for frequent injections in patients with diabetic retinopathy.
Read More
by MM360 Staff | May 22, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Ranibizumab injection (Susvimo; Genentech) could offer long-lasting vision preservation and reduce the need for frequent injections in patients with diabetic retinopathy.
Read More